Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St set for tepid open as oil prices fall, Treasury yields rise
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Vir Biotechnology Inc. (VIR) Misses Q3 EPS by 1c
November 2, 2023 4:35 PM EDTVir Biotechnology Inc. (NASDAQ: VIR) reported Q3 EPS of ($1.22), $0.01 worse than the analyst estimate of ($1.21). Revenue for the quarter came in at $2.6 million versus the consensus estimate of $8.71 million.
For earnings history and earnings-related data on Vir Biotechnology Inc. (VIR) click here.
... More